GQG Partners’s Allergan plc AGN Stock Holding History

GQG Partners’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-454,627	Closed	-$93.2M	–	60
2017 Q3	$93.2M	Buy	+454,627	New	+$106M	3.27%	10

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

GQG Partners's AGN Position: Q4 2017 in Review

GQG Partners sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 454,627 shares — an estimated $93.2M sold.

GQG Partners first reported a position in AGN in Q3 2017 and held it in 1 quarter. The position peaked at $93.2M in Q3 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

GQG Partners reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
GQG Partners sold 454,627 Allergan plc shares in Q4 2017, an estimated $93.2M.
GQG Partners first reported a position in Allergan plc in Q3 2017 and held it in 1 quarter.
GQG Partners's Allergan plc position peaked at $93.2M in Q3 2017.
1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on GQG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.